TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,720 | -66.3% | 2,000 | 0.0% | 0.01% | -62.5% |
| Q2 2023 | $49,680 | +65.2% | 2,000 | 0.0% | 0.02% | +45.5% |
| Q1 2023 | $30,080 | +154.1% | 2,000 | 0.0% | 0.01% | +83.3% |
| Q4 2022 | $11,840 | -1.3% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $12,000 | +33.3% | 2,000 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $9,000 | -52.6% | 2,000 | 0.0% | 0.01% | -44.4% |
| Q1 2022 | $19,000 | -50.0% | 2,000 | 0.0% | 0.01% | -52.6% |
| Q4 2021 | $38,000 | -43.3% | 2,000 | 0.0% | 0.02% | -50.0% |
| Q3 2021 | $67,000 | -4.3% | 2,000 | 0.0% | 0.04% | -2.6% |
| Q2 2021 | $70,000 | -27.1% | 2,000 | 0.0% | 0.04% | -38.1% |
| Q1 2021 | $96,000 | -7.7% | 2,000 | 0.0% | 0.06% | -18.2% |
| Q4 2020 | $104,000 | +395.2% | 2,000 | 0.0% | 0.08% | +250.0% |
| Q1 2020 | $21,000 | – | 2,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |